Home > Healthcare & Medical Devices > Home Sleep Apnea Testing Devices Market

Home Sleep Apnea Testing Devices Market Size by Test Type (Type 2, Type 3, Type 4), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI4439
  • Base Year: 2021
  • Report Format: PDF

Industry Overview

Home Sleep Apnea Testing Devices Market size was valued at around USD 811 million in 2021 and is anticipated to witness 17.2% CAGR by the end of 2028 owing to the growing adoption of novel sleep apnea monitoring methods and the launch of innovative home sleep apnea testing devices by major market players. Also, the increased R&D expenditure to offer technologically advanced solutions to treat sleep apnea is expected to improve home sleep apnea testing devices usage rates across the globe.
 

Home Sleep Apnea Testing Devices Market

Get more details on this report - Request Free Sample PDF
 

Growing product innovation in home sleep apnea tests such as integration of sensor systems, increased application of telemedicine, and self-adapting automated technology among others are estimated to promote the penetration of these devices. Also, market players are focusing on the ergonomic design of home sleep apnea testing devices to perform an easy self-administration of home sleep tests. Thus, such advancements are anticipated to offer substantial opportunities for the home sleep apnea testing devices market over the forecast period.
 

However, the clinical consequences and economic impact of obstructive sleep apnea and related sleep disorders are amongst the major factors hampering the adoption of home sleep apnea testing devices. The undetected and untreated sleep diseases may lead to abnormal physiology that may have severe implications comprising increased risk for cardiovascular disease, stroke, metabolic ailments, and high blood pressure among others.
 

As per recent research studies, patients with undiagnosed obstructive sleep apnea syndrome (OSAS) have higher medical costs than non-OSAS patients. These consequences related to sleep disorders result in a significant economic burden that is expected to be a major factor restricting the home sleep apnea testing devices market growth.
 

The COVID-19 pandemic has rendered a negative impact in 2020 on the home sleep apnea testing devices industry. Since then, the production facilities and supply chain were highly disrupted attributable to the high influx of coronavirus infected patients & nationwide lockdown scenario.
 

Most of the leading countries across the world imposed a total lockdown, and the focus was shifted to the surge in demand for essential products & services, that hampered the manufacturing and demand for home sleep apnea testing devices. In addition to these difficulties, other variables comprising a decline in visits by care providers to patients at home, especially during the first wave of the pandemic has affected the market revenue.
 

However, in 2021, the technological developments and incorporation of telemedicine in sleep apnea diagnosis using smartphone applications have increased diagnosis compliance and promoted the acceptance of home sleep apnea testing devices. Also, among COVID-19 infected patients, obstructive sleep apnea was related to an increased risk of infection and hospitalization, with a heightened risk of respiratory failure.
 

Owing to that incremental risk of sleep disorders, the need for home sleep apnea testing facilitated the market growth. Thus, the coronavirus outbreak has impacted the home sleep apnea testing devices market in the shorter run; however, the decreasing COVID-19 infection rates & patients and growing product demand is expected to drive home sleep apnea testing devices market share in the forthcoming period.
 

Rising prevalence of sleep apnea and related co-morbidities is expected to propel the market statistics

Increasing prevalence of sleep apnea and related co-morbidities across the globe is expected to promote the home sleep apnea testing devices market growth. Numerous studies across the globe have highlighted the increasing prevalence of sleep apnea and others sleep ailments comprising obstructive sleep apnea (OSA), insomnia, etc. As per the National Center for Biotechnology Information article published in 2019, the estimated number of people with obstructive sleep apnea (OSA) was highest in China, followed by the U.S., Brazil, and India.
 

As per the research article published in 2022, around 76% of people are suffering from at least one sleep issue in Brazil. In 2018, the German Sleep Society studies found that around 4.8 million people were suffering from chronic sleep disorders in Germany.
 

With the growing patient population, the industry is expected to foresee tremendous growth attributable to the rising preference for home sleep apnea testing devices due to their reliability and support in the management of sleep disorders efficiently. Hence, as home sleep apnea tests have delivered a simplified and advanced solution for screening patients suffering from sleep disorders, the market is anticipated to experience unprecedented growth in the coming years.
 

Increasing awareness regarding home sleep apnea tests is anticipated to drive the business landscape

Sleep disorders inflict significant disease and financial burden & their prevalence is increasing, especially in developing countries including China, Brazil, India, etc. This is anticipated to stimulate the home sleep apnea testing devices market revenue. Owing to low awareness regarding these disorders, many of these ailments go unaddressed and untreated in clinical practice.
 

Further, to promote awareness and enhance the management of sleep disorders, the government authorities have initiated public education, training for clinicians, and surveillance & monitoring campaigns. The government authorities are collaboratively working in association with public organizations across the globe. Public organizations such as the German Sleep Society, the Chinese Sleep Research Society, the Canadian Sleep Society, and the National Sleep Foundation among others are actively operating to promote research, education, and awareness pertaining to home sleep apnea testing (HSAT).
 

Growing usage of type 3 home sleep apnea testing devices will spur the market forecasts

Global Home Sleep Apnea Testing Devices Market Share, By Test Type

Get more details on this report - Request Free Sample PDF
 

Based on test type, the market is segmented as type 2, type 3, and type 4. The type 3 home sleep apnea testing devices segment was valued at more than USD 533 million in 2021 owing to the soaring demand and rising awareness regarding the benefits offered by portable type 3 devices in the evaluation of multiple sleep disorders.
 

The technological advancements in the field of home sleep apnea tests (HSATs) are augmenting their use in the diagnosis of sleep apnea. For instance, ApneaTrak, a home sleep apnea testing device meets clinical requirements for unattended Type 3 sleep studies. This device has all channels required to record a type 3 study comprising oximetry, nasal pressure, etc. Further, the increased adoption and launch of user-friendly type 3 home sleep apnea testing devices for use in home care settings are the key factors driving the industry growth.
 

For instance, CleveMed announced the commercialization of its SleepView monitor, a portable type 3 home sleep testing device that meets American Academy of Sleep Medicine (AASM) recommended guidelines.  Such product launches are expected to spur the use of these devices. Thus, with a focus of market players on the development of technologically advanced home sleep apnea testing devices to cater to the increasing demand, the market is predicted to hold significant revenue in the coming years.
 

High adoption of technologically advanced products in North America will stimulate the regional market forecasts

Global Home Sleep Apnea Testing Devices Market, By Region

Get more details on this report - Request Free Sample PDF
 

U.S. home sleep apnea testing devices market held the largest revenue share of more than 91% in 2021 owing to the presence of major industry players, an upsurge in the number of individuals suffering from sleep issues, etc. As per the Sleep Foundation 2021 data, snoring was estimated to affect 57% of men and 40% of women in the U.S.
 

According to the American Journal of Managed Care article 2020, around 30% to 40% of adults in the U.S. report symptoms of insomnia each year. These statistics are highlighting the augmented need for home sleep studies that incorporate the use of home sleep apnea testing devices efficiently. The home sleep apnea testing devices have become a significant and cost-effective tool for the diagnosis of complications related to sleep disorders, thereby stimulating the product demand positively.
 

As per the National Center for Biotechnology Information (NCBI) studies, home monitoring for obstructive sleep apnea (OSA) resulted in 42% savings in diagnostic costs. Thus, the adoption of home sleep apnea testing devices has been significantly rising in the U.S. over the past few years. Additionally, the presence of prominent players such as Resmed, Itamar Medical Inc., and Natus Medical Inc. among others in the country are engaged in new product development & commercialization that facilitates market expansion in the U.S.
 

Strategic initiatives implemented by major market players will augment the market growth

Some of the major market players operating in the home sleep apnea testing devices industry are Compumedics Limited, Natus Medical Inc., Koninklijke Philips N.V., SOMNOmedics GmbH, and Resmed among others. These players are engaged in strategic acquisitions, mergers, collaborations, partnerships, expansions, and product launches among other strategies to maintain a competitive edge. These market players also focus on research and development activities that enables in garnering maximum market share.
 

Recent industry developments:

  • In October 2021, Resmed announced the acquisition of Ectosense, a company involved in the development of cloud-connected home sleep test (HST) devices. This acquisition supported the company to broaden its home sleep apnea testing devices portfolio and strengthen its market presence.
     
  • In October 2020, Itamar Medical Inc. received the Pharmaceuticals and Medical Devices Agency (PMDA) approval for its WatchPAT 300 home sleep apnea testing device. This approval granted the use of this device in Japanese market. This strategic move aided company in increasing its customer base and bolstered its market presence.   
     

Home sleep apnea testing devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028, for the following segments:

By Test Type

  • Type 2
  • Type 3
  • Type 4

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
       
Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for home sleep apnea testing devices accounted for USD 811 million in 2021 and is expected to record a CAGR of 17.2% from 2022 to 2028 driven by the increasing R&D expenditure for offering technologically advanced solutions.

U.S. market for home sleep apnea testing devices held over 91% of the North America revenue share in 2021 and is set to expand considering the presence of key industry players.

Type 3 home sleep apnea testing devices market value surpassed USD 533 million in 2021 and is estimated to depict lucrative growth owing to the increasing awareness regarding the multiple benefits offered by these devices.

Prominent companies in the home sleep apnea testing devices industry comprise Natus Medical Inc., Compumedics Limited, Resmed, SOMNOmedics GmbH, Koninklijke Philips N.V., and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Apr 2022
  • Companies covered: 14
  • Tables & Figures: 79
  • Countries covered: 18
  • Pages: 100

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount